EQHA logo

EQ Health Acquisition (EQHA) Financials

Balance sheets

30 Sept 202230 June 202231 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202130 Sept 2020

Total Assets

$221.5 M(+0.5%)$220.5 M(-0.1%)$220.6 M(+0.1%)$220.4 M(-0.3%)$221.1 M(-0.0%)$221.1 M(-0.1%)$221.4 M(+232930.5%)$95.0 K

Current Assets

$405.0 K(+39.0%)$291.4 K(-38.4%)$473.3 K(+64.9%)$287.0 K(-71.6%)$1.0 M(-5.5%)$1.1 M(-21.0%)$1.4 M(+5316.8%)$25.0 K

Non Current Assets

$221.1 M(+0.4%)$220.3 M(+0.0%)$220.2 M(+0.0%)$220.1 M(+0.0%)$220.1 M(+0.0%)$220.0 M(0%)$220.0 M(+314221.1%)$70.0 K

Total Liabilities

$10.9 M(-5.6%)$11.6 M(-28.1%)$16.1 M(-14.1%)$18.8 M(-6.7%)$20.1 M(-7.5%)$21.8 M(+31.4%)$16.6 M(+23224.8%)$71.0 K

Current Liabilities

$1.9 M(-17.7%)$2.3 M(-6.3%)$2.4 M(+18.3%)$2.0 M(-12.9%)$2.3 M(+37.1%)$1.7 M(+958.0%)$160.7 K(+126.3%)$71.0 K

Long Term Liabilities

$9.1 M(-2.7%)$9.3 M(-32.0%)$13.7 M(-18.0%)$16.7 M(-5.9%)$17.8 M(-11.3%)$20.1 M(+22.3%)$16.4 M(+100.0%)$0.0

Shareholders Equity

$210.6 M(+0.8%)$208.9 M(+2.2%)$204.5 M(+1.4%)$201.6 M(+0.3%)$200.9 M(+0.8%)$199.3 M(-2.7%)$204.8 M(+853310.0%)$24.0 K

Book Value

$210.6 M(+0.8%)$208.9 M(+2.2%)$204.5 M(+1.4%)$201.6 M(+0.3%)$200.9 M(+0.8%)$199.3 M(-2.7%)$204.8 M(+853310.0%)$24.0 K

Working Capital

-$1.4 M(+26.1%)-$2.0 M(-1.6%)-$1.9 M(-10.6%)-$1.7 M(-32.0%)-$1.3 M(-109.5%)-$630.1 K(-152.8%)$1.2 M(+2694.6%)-$46.0 K

Cash And Cash Equivalents

$301.8 K(+186.3%)$105.4 K(-60.7%)$268.3 K(+436.6%)$50.0 K(-93.7%)$793.1 K(-24.9%)$1.1 M(-20.8%)$1.3 M(+5228.0%)$25.0 K

Accounts Payable

----$2.3 M(+39.2%)$1.7 M(+1390.7%)$110.7 K-

Accounts Receivable

--------

Short Term Debt

$600.0 K(+20.0%)$500.0 K(0%)$500.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0-

Long Term Debt

--------

Total Debt

$600.0 K(+20.0%)$500.0 K(0%)$500.0 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0

Current Ratio

0.2(+69.2%)0.1(-35.0%)0.2(+42.9%)0.1(-67.4%)0.4(-31.8%)0.6(-92.5%)8.4(+2308.6%)0.3

Quick Ratio

--------

Inventory

--------

Retained Earnings

-$10.3 M(+6.5%)-$11.1 M(+28.6%)-$15.5 M(+15.8%)-$18.4 M(+3.6%)-$19.1 M(-3963.7%)-$469.2 K(-109.4%)$5.0 M(+500030.0%)-$1000.0

PB Ratio

1.3(0%)1.3(-2.3%)1.3(0%)1.3(-1.5%)1.3(+0.8%)1.3(+2.3%)1.3-

Income statements

30 Sept 202230 June 202231 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202130 Sept 2020

EPS

$0.1(-62.8%)$0.2(+46.6%)$0.1(+450.0%)$0.0(-66.7%)$0.1(+106.0%)-$1.0(-287.6%)$0.5-

TTM EPS

$0.4(0%)$0.4(+143.7%)-$0.8(-109.3%)-$0.4(+5.0%)-$0.4(+12.9%)-$0.5(-187.6%)$0.5-

Revenue

--------

TTM Revenue

--------

Total Expenses

$206.0 K(-10.3%)$229.7 K(+12.4%)$204.3 K(-49.3%)$403.3 K(-41.6%)$690.3 K(-62.1%)$1.8 M(+507.1%)$300.4 K-

Operating Expenses

$206.0 K(-10.3%)$229.7 K(+12.4%)$204.3 K(-49.3%)$403.3 K(-41.6%)$690.3 K(-62.1%)$1.8 M(+507.1%)$300.4 K-

Cost Of Goods Sold

--------

TTM Cost Of Goods Sold

--------

Gross Profit

--------

TTM Gross Profit

--------

Gross Margin

--------

Operating Profit

-$206.0 K(+10.3%)-$229.7 K(-12.4%)-$204.3 K(+49.3%)-$403.3 K(+41.6%)-$690.3 K(+62.1%)-$1.8 M(-507.1%)-$300.4 K-

TTM Operating Profit

-$1.0 M(+31.7%)-$1.5 M(+51.1%)-$3.1 M(+3.0%)-$3.2 M(-14.3%)-$2.8 M(-32.5%)-$2.1 M(-607.1%)-$300.4 K-

Operating Margin

--------

Net Income

$1.7 M(-62.8%)$4.4 M(+53.1%)$2.9 M(+325.8%)$680.6 K(-57.0%)$1.6 M(+128.9%)-$5.5 M(-153.8%)$10.2 M-

TTM Net Income

$9.7 M(+0.7%)$9.6 M(+3227.5%)-$306.9 K(-104.4%)$7.0 M(+10.8%)$6.3 M(+33.7%)$4.7 M(-53.8%)$10.2 M-

Net Margin

--------

EBIT

-$206.0 K(+10.3%)-$229.7 K(-12.4%)-$204.3 K(+49.3%)-$403.3 K(+41.6%)-$690.3 K(+62.1%)-$1.8 M(-507.1%)-$300.4 K-

TTM EBIT

-$1.0 M(+31.7%)-$1.5 M(+51.1%)-$3.1 M(+3.0%)-$3.2 M(-14.3%)-$2.8 M(-32.5%)-$2.1 M(-607.1%)-$300.4 K-

EBITDA

-$206.0 K(+10.3%)-$229.7 K(-12.4%)-$204.3 K(+49.3%)-$403.3 K(+41.6%)-$690.3 K(+62.1%)-$1.8 M(-507.1%)-$300.4 K-

TTM EBITDA

-$1.0 M(+31.7%)-$1.5 M(+51.1%)-$3.1 M(+3.0%)-$3.2 M(-14.3%)-$2.8 M(-32.5%)-$2.1 M(-607.1%)-$300.4 K-

Selling, General & Administrative Expenses

--------

TTM SG&A

--------

Depreciation And Amortization

--------

TTM D&A

--------

Interest Expense

--------

TTM Interest Expense

--------

Income Tax

$246.9 K(+16360.0%)$1500.0--$0.0(0%)$0.0--

TTM Income Tax

$248.4 K(+16460.0%)$1500.0--$0.0(0%)$0.0--

PE Ratio

28.1(+0.5%)28.0----18.3-

PS Ratio

--------

Cashflow statements

30 Sept 202230 June 202231 Mar 202231 Dec 202130 Sept 202130 June 202131 Mar 202130 Sept 2020

Cash From Operations

-$97.6 K(+73.1%)-$362.4 K(-28.6%)-$281.8 K(+62.1%)-$743.0 K(-200.2%)-$247.5 K(+10.5%)-$276.4 K(-29.8%)-$212.9 K-

TTM CFO

-$1.5 M(+9.2%)-$1.6 M(-5.5%)-$1.5 M(-4.7%)-$1.5 M(-100.8%)-$736.8 K(-50.6%)-$489.3 K(-129.8%)-$212.9 K-

Cash From Investing

$194.0 K(-2.8%)$199.5 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(+100.0%)-$220.0 M-

TTM CFI

$393.5 K(+97.2%)$199.5 K(+100.0%)$0.0(+100.0%)-$220.0 M(0%)-$220.0 M(0%)-$220.0 M(0%)-$220.0 M-

Cash From Financing

$100.0 K(+100.0%)$0.0(-100.0%)$500.0 K(+100.0%)$0.0(+100.0%)-$15.0 K(-100.0%)$0.0(-100.0%)$221.5 M-

TTM CFF

$600.0 K(+23.7%)$485.0 K(0%)$485.0 K(-99.8%)$221.5 M(0%)$221.5 M(-0.0%)$221.5 M(0%)$221.5 M-

Free Cash Flow

-$97.6 K(+73.1%)-$362.4 K(-28.6%)-$281.8 K(+62.1%)-$743.0 K(-200.2%)-$247.5 K(+10.5%)-$276.4 K(-29.8%)-$212.9 K-

TTM FCF

-$1.5 M(+9.2%)-$1.6 M(-5.5%)-$1.5 M(-4.7%)-$1.5 M(-100.8%)-$736.8 K(-50.6%)-$489.3 K(-129.8%)-$212.9 K-

CAPEX

--------

TTM CAPEX

--------

Dividends Paid

--------

TTM Dividends Paid

--------

TTM Dividend Per Share

--------

TTM Dividend Yield

--------

Payout Ratio

--------